As HCC is a typical inflammation-related cancer, these biologic effects of IL-18 might thus be implicated with HCC development, suggesting that abnormal expression of IL-18 could be associated with the pathogenesis of this disease (Yang et al., 2013). Here, IL18 is linked to hepatocellular carcinoma.